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Functional eubacteria species along 
with trans-domain gut inhabitants 
favour dysgenic diversity in oxalate 
stone disease
Mangesh V. Suryavanshi  1,2, Shrikant S. Bhute1,3, Rahul P. Gune4 & Yogesh S. Shouche  1
Analyses across all three domains of life are necessary to advance our understanding of taxonomic 
dysbiosis in human diseases. In the present study, we assessed gut microbiota (eubacteria, archaea, 
and eukaryotes) of recurrent oxalate kidney stone suffers to explore the extent of trans-domain and 
functional species dysbiosis inside the gut. Trans-domain taxonomic composition, active oxalate 
metabolizer and butyrate-producing diversity were explored by utilizing frc-, but-, and buk- functional 
gene amplicon analysis. Operational taxonomic units (OTUs) level analyses confound with the 
observation that dysbiosis in gut microbiota is not just limited to eubacteria species, but also to other 
domains like archaea and eukaryotes. We found that some of healthy eubacterial population retained 
together with Oxalobacter formigenes and Lactobacillus plantarum colonization in disease condition 
(p < 0.001 & FDR = 0.05). Interestingly, trans-domain species diversity has been less shared and 
dysgenic taxa augmentation was found to be higher. Oxalate metabolizing bacterial species (OMBS) 
and butyrate-producing eubacteria species were found to be decreased in Oxalobacter non-colonizers; 
and Prevotella and Ruminococcus species which may contribute to oxalate metabolism and butyrate 
synthesis as well. Our study underscores fact that microbial dysbiosis is not limited to eubacteria only 
hence suggest the necessity of the trans-domain surveillance in metabolic diseases for intervention 
studies.
The human gut microbiome is considered as an effective metabolic organ; several host vital metabolite depend-
encies have been systematically incorporated and disparagingly executed within gut by it. In fact, causes and 
consequences of many metabolic disorders have been rationalized using high correlation with specific gut inhab-
itants. Dysbiosis has been usually attributed to eubacteria as previously reported in literature. Variations in the 
eubacterial community referred to as dysbiosis; disturbs the host health status and is found actus-reus principally 
in intestinal syndromes. Upon dissecting non-intestinal metabolic disorders like obesity1, cardiovascular disease2 
and chronic kidney disease3, it was understood that dysbiosis in gut eubacteria has partial verdict and indicates 
towards the direction for interventions in the diagnosis, treatment, and probable prevention. Most of the micro-
biome components have originated from the eubacteria and are diverse in genes, genomes, and their products in 
gut ecology4. However, other components remain elusive regarding knowledge of their diversity and role in host 
health.
Trans-domain gut inhabitants include eubacteria, archaea, eukaryotes and their diversity are the key players 
in gut ecology. Trans-domain diversity inside the human gut is not yet fully explored in healthy state as well as 
in impaired health condition. In some reports generated on diabetes; Methanobacter (archaea) and Aspergillus 
species (filamentous fungi) were found to be prevalent in the diabetic state5.
Using high throughput sequencing methods, the variations in healthy gut flora were observed and disease 
associated bacteria were traced universally. The persistent colonization of unique gut microflora involved in 
non-intestinal metabolic disorders has been correlated with host health conditions. Moreover, disease associated 
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flora for kidney stone disease was manifested and re-enlisted specifying signature flora in canines6, and humans 
by prognosticative ways7. The panoptic power of high throughput sequencing methods was confined to 
describe the species level taxonomic features of gut bacteria as it has limitations of short-read length as output. 
Prognosticative detection of disease associated flora is still elusive mainly due to the lack of the species-level 
taxonomic assignments. Apparently, defining the role of species of the gut inhabitant, along with qPCR-based 
species-specific detection of Oxalobacter formigenes have been indispensable in kidney stone endurers8 and only 
the metagenomic sequencing approach has been found productive9,10.
Functional metagenome strategy has proven to support the hypothesis related to the metabolic capacities and 
its diverse origin in the health status. Functional capacities of the eubacteria from the previous observations11, 
gave clues about the dynamics observed in the hyperoxaluria condition due to their activities. Here, we are report-
ing a comprehensive catalog of functional gene diversity using functional metagenomic library. We used the 
functional genes such as frc-gene to decipher OMBS diversity and but- and buk-gene for butyrate-producing bac-
terial species (SCFA producer) diversity. Comprehensive reports on species level diversity in gut inhabitants and 
kidney stone associated dysbiosis in human subjects were lacking. In the present study, we focused on assessment 
of species-level differences between the compositions of the intestinal flora in individuals with recurrent kidney 
stone to that of healthy individuals based on 16S rRNA gene traditional clone libraries for the eubacteria, 18S 
rRNA gene for microeukaryotes and ITS region for the fungal species diversity analysis.
Results
Posited emergence of exploitation of use of the indigenous gut bacteria for recurrent episode repression was rec-
ommended12. The colonization of Oxalobacter formigenes, a known oxalotrophic bacterium was directly linked 
to the disease prevalence8. In addition to the case-control study for recurrent kidney stone disease11, included 
healthy control study subjects to check whether that certain other healthy gut associated bacterial species may 
also dwell with the recurrent oxalate stone episodes. The comparatives in healthy subjects (HLT) and kidney stone 
disease subjects (KSD) (Supplementary Table S1) has been explained by using amplification and sequencing of 
functional genes and trans-domain molecular marker genes (Table 1).
Comparison of eubacterial species and its functional diversity in HLT and KSD. The oxa-
late metabolizing bacteria accounted for the highest at 88.13% among the enriched in KSD and found to be 
unique feature of oxalate kidney stone patients (KSD) (Fig. 1a). The qPCR results show increased abundance of 
frc-gene in KSD in comparison to the HLT. However, the Oxalobacter formigenes and Lactobacillus plantarum 
abundance was decreased in the KSD group. We had already demonstrated the bacterial dysbiosis and enrich-
ment of unique OMBS in subpopulation of this cohort, we reported the bacterial dysbiosis and enrichment 
of unique OMBS11. We found that the colonization of Oxalobacter in the KSD subjects retains the 118 out of 
785 OTUs detected (Kruskal-Wallis test, p <= 0.001 & FDR = 0.05), reflecting the 20.08% of HLT group flora 
(Supplementary File S2). Such keen observation depicts that the retention of HLT microbiome could be achieved 
by the Oxalobacter formigenes and Lactobacillus plantarum.
The metagenomic imputation demonstrated the differential abundance of genes involved in oxalate metab-
olism in KSD (Wilcoxon sum rank test, p =< 0.005) (Fig. 1b). We found out that certain families are character-
istics of disease in the KSD subjects and in the different subjects. Certain bacterial families like Bacteriodaceae, 
Enterobacteraceae, and Porphyromonadaceae were found enriched and Mogibacteriaceae, Paraprevotellaceae, 
Alcaligenaceae, Pasterallaceae, Spirochaetaceae and Streptococcaceae were depleted in KSD (Welch’s t-test, 
Bacterial species
Explanations for Involvement in various diseases
Microbiota associated Pathological detection
Lactobacillus mucosae NA Dental caries and Dental lesions51
Olsenella umbonata NA Dental caries and Dental lesions52
Collinsella aerofaciens Inflammatory Bowel Disease53 Colitogenic bacteria in inflammation54
Streptococcus sanguinis Inflammatory Bowel Disease53 Colitogenic bacteria in inflammation54
Eubacterium siraeum Behcet’s disease
55, exhibit the highest 
affinities for Candida albicans56 Colitogenic bacteria in inflammation
57
Streptococcus lutetiensis NA Children diarrhoea58
Turicibacter sanguinis
Children with Pervasive Developmental 
Disorder Not Otherwise Specified 
(PDD-NOS) and autism (AD)59
NA
Veillonella dispar Patients with hepatitis B liver cirrhosis60 Endocarditis61
Comamonas testosteroni NA Bacteraemia62, Acute Appendicitis63
Escherichia fergusonii NA Bacteraemia
64, Pneumonial 
pathogenesis65
Klebsiella pneumoniae NA Pneumonial pathogenesis66
Succinivibrio dextrinosolvens Associated with cancer development67 NA
Megamonas funiformis Effects on Immunity and Disease68 NA
Catenibacterium mitsuokai Effects on Immunity and Disease68 NA
Table 1. Eubacterial species enriched in KSD subjects and their possible involvement in health impairments. 
*NA = Not any literature found.
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p =< 0.001 & FDR = 0.05) group (Fig. 1c,d). As reported earlier13; applying the hypergeometric test function 
(p <= 0.001), we found that such differential bacterial families are present and have their own role in KSD not by 
chance mechanism.
Figure 1. Comparatives in eubacterial colonization status of HLT and KSD subjects. (a) qPCR based quantitative 
estimation of Oxalobacter formigenes, total OMBS diversity (through frc-gene) and Lactobacillus plantarum in HLT 
and KSD (n = 72). (b) Evaluation of specific metabolism capacities of eubacteria, and respective KEGG Orthology 
for the enzymes involved in metabolic phenotype according to the predicted metagenome observed in HLT and 
KSD. (c) Heat map showing family level differences in HLT and different groups in KSD subjects. The data used to 
generate these graphs has been partially adopted from Suryavanshi et al.11.
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In connection with functional capacities, surveillance of functional eubacteria was accessed through the 
frc-, but-, and buk-genes in the subpopulation (Supplementary Table S3). The species level diversity of func-
tional genes which are unique present in comparative, reported in (Fig. 2). Eleven bacterial species accessed 
through frc-gene were found to be completely absent in the KSD subpopulations in comparison to the healthy 
subjects. The functional gene diversity pattern of KSD was found dislodged to the HLT. Similarly, 23 bacterial 
species accessed through buk-gene were not found to be present in the KSD group. The functional group assessed 
through buk-gene revealed that only four bacterial species found in the healthy subjects diminished completely 
in the KSD subjects.
Deducing the change in eubacteria species through clone library generation approach in 
KSD. For the bacterial species diversity characterization, we obtained 16S rRNA gene clones and PCR-DGGE 
fingerprinting patterns of some randomly selected subjects. Total 6400 clones were randomly picked and 
sequenced from fourteen fecal samples from which 5057 good quality sequences of more than 750 base pairs 
with an average of 361 clones per sample were obtained. Measures of alpha diversity such as Cho1, Shannon 
and Simpson indices showed significant decrease in overall diversity in KSD subjects (Supplementary Table S4). 
All the gut communities contained sequences from 7 bacterial phyla (Firmicutes, Bacteroidetes, Proteobacteria, 
Cyanobacteria, Tenericutes and Thermi). Denaturant gradient gel electrophoresis of eubacterial 16S rRNA gene 
revealed differential fingerprinting pattern for KSD and HLT individuals suggestive of bacterial community shift 
as indicated by similarity profile of DGGE band pattern for all the subjects (Fig. 3a). We also analyzed the OTU 
abundance from each sample which corresponded to 23 different families. The bacterial families were differ-
entially abundant in the KSD subjects (Supplementary Fig. 1). PCoA analysis of unweighted UniFrac distance 
matrix revealed distinct clustering of HLT subjects than discrete spread of KSD subjects (Fig. 3b). Clustering of 
IKF values obtained from K-Shuff revealed grouping of all HLT subjects (Fig. 3c).
We found that 833 and 90 OTUs were assigned to genus and species level identity by >95.0% and >97.0% of 
sequence identity cut off value respectively (Supplementary Table S5). Out of 90 bacterial species, 33 were com-
pletely depleted and 19 were newly augmented in KSD subjects over HLT. While 12 bacterial species (p =< 0.01) 
were found to be differentially present in KSD subjects (Fig. 3d). These results suggest that some bacterial spe-
cies were found to be absent in the recurrent oxalate stone episodes and some new bacterial species were found 
to be present in such conditions. All newly augmented flora were found to be mostly aerobic and facultative 
Streptococcus sanguinis, Bacillus sonorensis, Comamonas testosterone, Klebsiella pneumoniae subsp. pneumoniae, 
Escherichia fergusonii and Veillonella denticariosi. Deserting the differential eubacteria species in KSD, most are 
perpetually positive in their involvement in various health impairments and sometimes may act as etiological 
agents (Table 1).
Differences in gut inhabiting archea, eukarya and fungal species in KSD. As far as the 
trans-domains are concerned, eubacteria along with archaea, eukaryotes and fungi are the gut inhabitants and 
major diversity players (Supplementary Table S6). We found that the 11 members of archaea, 7 of eukarya and 
6 fungal ubiquitous species of HLT group were absent in KSD subjects (Fig. 4). The co-occurrence pattern illus-
trated a comprehensive change in the microbial community of the KSD subjects in comparison to the healthy 
individuals (Fig. 5).
Discussion
Kidney stones are believed to be multi-factorial diseases and are predominantly found in male than in female14. 
Although, the oxalate stones in urinary system are perceived as a part of hyperoxaluria in many individuals may 
with recurrent episodes, and sometimes leading to chronic disease15. In last two decades, satisfactory regime for 
diagnosis and treatment of recurrent kidney stones focused on the factors affecting handling of oxalate by the 
intestine as a part of homeostasis driven by the host16 and rather the structure and composition of gut microbial 
communities inside the gut17. Dysbiosis associated with pathogenesis of the kidney and the large intestine micro-
biome would be the bi-directional operative axis for its proper functioning. In connection with altered microflora 
with respect to chronic kidney disease18,19, the specific reports on alteration in gut microbiome associated with 
kidney stones of human subjects and their metabolic potentials are little scanty. We present this study as an 
attempt to elucidate the changes in the trans-domain microbial species including eubacteria, archaea, fungi and 
micro-eukaryotes, and their function in lieu of kidney stone disease.
Eubacterial family and their functional alterations are characteristics of oxalate stone dis-
ease. Oxalate influences the colonic microbial metabolism whereas; microbial-related metabolites are 
speculated to be involved in the progression of the kidney disease. In the present study, we applied two 
culture-independent approaches namely 16S rRNA clone library and PCR-DGGE to reveal bacterial community 
structure of gut flora in KSD subjects. Qualitative and quantitation perturbations in functional eubacteria species 
also were found.
Major players like Oxalobacter formigenes and Lactobacillus plantarum species are the key eubacteria in Indian 
healthy gut and their quantitative values provides the reference material in colonization status even in oxalate 
kidney stone disease. Lactobacillus plantarum species has been reported from the healthy gut flora in the same 
population20, and here we found out negative correlation with hyperoxaluria condition even high with their oxa-
late tolerance capacity evaluated previously.
From clustering pattern based on PCR-DGGE and PCoA plot based on unweighted UniFrac we observed that 
KSD subjects are dispersed as compared to HLT subjects. We speculate that this may be due to more different 
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OTU composition of KSD than HLT and among them. Inter-individual difference among the KSD subjects could 
be because of recurrent episodes of kidney stones and different number of stones.
Our findings on human subjects showing increased abundance of Firmicutes and decreased abundance of 
Bacteroidetes are in agreement with the previous studies relating to the gut microflora and the oxalate stones 
in humans7,21 and even in the dogs6. However, at the genus level various distinctions are observed confirming 
the fact that the gut microbiota varies according to the host type22. We observed dominance of genera such as 
Figure 2. Heat map showing the status of functional eubacteria in different groups in tested subjects. (a) heat 
map for total OMBS diversity players observed by frc-gene sequence analysis, and (b,c) reflects the Butyrate 
(known-SCFA) producer observed by but- and buk-gene sequence analysis respectively. Only presence-absence 
data represented here whereas the OMBS diversity data has been adopted from Suryavanshi et al.11.
www.nature.com/scientificreports/
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Collinsella and reduction in genera like Bacteroides, Deinococcus and Sutterella in KSD group. Collinsella is known 
to be involved in deconjugation of bile acids23 and is also associated with disease like symptomatic atherosclero-
sis24. Thus, high abundance of Collinsella in the gut microbiota may be an indicator of a disturbed gut. Bacterial 
phylotypes of Bacteroides genera are potentially involved in glycan synthesis25. Highly robust bacteria such as 
Deinococcus have been shown to be adapted for human gut colonization26 and members of Sutterella have been 
found to be linked with autism disease in children27.
The change in the gut microbial community structure of KSD patients in comparison with the healthy subjects 
could be attributed to the diet patterns. Strict dietary restrictions in advanced CKD for high-fiber products could 
affect the makeup and/or metabolism of the gut flora3.
Alterations are dislodged to the functional eubacteria species diversity. On the other hand, spe-
cies level dysbiosis was found in disease conditions whereas, certain bacterial species which were involved in 
Figure 3. Compositional differences in eubacteria diversity in study subpopulations (HLT = 07 and KSD = 07). 
Clustering pattern of tested subpopulation through (a). PCR-DGGE fingerprint analysis in UPGMA algorithm, 
(b). PCoA plot and (c). IKF values on scattered plot derived from K-Shuff algorithm. (d) Species level diversity 
differences observed in HLT and KSD subjects, whereas shared species with significant difference (Welch’s test 
p <= 0.05) were annotated in bubble plot.
www.nature.com/scientificreports/
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other diseases were augmented. Lactic acid fermenting-mucosa associated bacteria, Olsenella umbonata has abil-
ity to produce 4-methylphenol (p-cresol) from p-hydroxyphenylacetic acid28. Absolute findings of novel bacterial 
species in human gut are leading towards greater exploration of gut microflora then we have ever speculated29. 
Figure 4. Trans-domain species diversity present in 5 groups (a) Diagrammatic illustration of unique Trans-
domain species in each group, whereas comparison in HLT and KSD subjects only. The color of petal indicates 
the number of unique species either in HLT or KSD subject within 5 group. (b–d) Heatmap showing the species 
diversity in each five groups with pink (archaea), green (microeukaryotes) and violet (fungi) represents actual 
trans-domain components. Diversity was studied by the conserved genes such as 16S rRNA gene (archaea and 
eubacteria), 18S rRNA gene (microeukaryotes) and ITS region (fungi) sequencing. Presence and absence of 
gene bearing species data utilized for the representation.
www.nature.com/scientificreports/
8SCieNTifiC RepORtS |         (2018) 8:16598  | DOI:10.1038/s41598-018-33773-5
Some of species like Eubacterium siraeum has been reported for biosynthesis of conjugated linoleic acid30 and 
Klebsiella pneumoniae have a phospholipase D family protein as a novel virulence factor31.
For reduction in glycans and complex carbohydrates helping bacteria were depleted Bacteroides plebeius32. 
Propionate production within the human gut microbiota was reported including Dialister succinatiphi-
lus33. Eubacterium eligens has known for dietary fibers production by pectin34. Downshift pH 5.5 resulted in 
Faecalibacterium prausnitzii lowering and underlying atopic dermatitis35. Variety of carbohydrates including the 
inulin, pectin can be metabolized by Faecalibacterium and have efficient processing ability of D-glucosamine and 
N-acetyl-d-glucosamine36. Faecalibacterium prausnitzii is known anti-inflammatory commensal flora37 which 
have the ability to grow at oxic–anoxic interphases38. This fact suggests that either hyperoxaluric condition may be 
responsible for enrichment of some oxalate utilizing bacterial genera that are not observed in healthy subjects; or 
due to the disturbed microflora inside the gut may impart the hyperoxaluric condition to the host are still unclear.
Our PICRUSt analysis revealed several important findings of gut microbiome in relation to calcium oxalate 
stone formation. Inositol, which is also known as phytate seems to have important role in preventing calcium 
oxalate stone formation. Levels of inositol was found to be significantly reduced in people with calcium oxalate 
stone formers39 and in rat models phytate has been shown to have inhibitory role on deposition of calcium oxalate 
stones40. Previous study has shown dissolution effect of lysine on calcium oxalate by considerably lowering the 
super-saturation of the urine41. Similarly, there are reports showing reduced levels of tyrosine in stone formers 
compared to control subjects42. Interestingly, our results showed significant degradation of lysine and metabo-
lism of tyrosine by gut microbiota in KSD subjects suggesting that effective concentration of lysine and tyrosine 
needed for dissolution of calcium oxalate stones was never attained in these subjects, thus chances of recurrent 
stone formation are increased in these subjects. We observed that gut microbiota of KSD subjects was dominant 
with gene families involved in fatty acid synthesis. Fatty acid and bile acid malabsorption is a one of the risk fac-
tors for hyperoxaluria in mal-absorptive patients and low fat diet is often advocated to these patients to prevent 
hyperoxaluria43.
Trans-Domain gut inhabitants favor the dysgenic diversity in oxalate disease. In the human gut 
diverse prokaryotic populations have been studied well compared with that of the eukaryotic fraction which are 
still underway29,44. The current studies on the gut resident microbial eukaryotes give clues for either beneficial 
or commensal. Elucidating such crucial piece of gut community to cause of several diseases might be potential 
treatment factor cannot be denied.
Although the methanogens, species like Methanobrevibacter smithii and Methanosphaera stadtmanae have the 
most dominant archaeal groups inside the human gut45,46. The two fungal phyla Ascomycota (which includes the 
genera Candida and Saccharomyces) and Basidiomycota are the prominent fungal diversity47,48. Our observation 
is also in agreement with the archaeal and fungal diversity in Indian population. Previous reports have indicated 
that dysbiosis in the fungal population of the human gut can be associated with intestinal disease and infections. 
In the present study, there is an evident change in the eukaryotic, archaeal and fungal populations in KSD patients 
as compared with healthy individuals. The results suggest that the selection pressure on the part of the host and 
the microbes shapes the structure, composition, and function of not only the bacterial populations but also the 
trans-domain diversity. However, this is the first report indicating a direct correlation between the kidney stone 
disease and altered diversity of gut microflora involving archaeal and fungal participants. Despite maintaining of 
Figure 5. Diagrammatic illustration of Trans-domain species found in the tested subjects. An overall number 
of Trans-domain species (eubacteria, archaea, fungi, and microeukaryotes) in HLT and KSD subjects were 
demonstrated and presented only on presence or absence data through igraph. The Tran-domain species which 
were uniquely distributed in either HLT or KSD subjects are represented by red (HLT), blue (KSD) and violet 
color for common species.
www.nature.com/scientificreports/
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an ecosystem the colonization of Oxalobacter formigenes inside the human gut as healthy gut flora10 describing 
the withholds host health features and other core microbiome as well9. As their absence corresponds to enhanced 
level of oxalate in systemic fluid49, replacement therapy granted the recovery from hyperoxaluria condition in 
humans50. Demonstrating the colonization status of Oxalobacter formigenes, we speculate the major role of this 
bacterium in settlement of functional eubacteria and trans-domain species as well as in symptomatic phase of 
hyperoxaluria i.e. oxalate stone disease (Fig. 6). Presence of Oxalobacter formigenes has positively impacted on 
Lactobacillus plantarum, known butyrate producers and Bacteriodetes members’ colonization and inversely 
related to Methanobrevibacter smithii, filamentous fungi and Fermicutes members’ in this Indian population 
study.
In conclusion, our study reports that the dysbiosis of gut microbial communities in recurrent oxalate kidney 
stone sufferers are limited not just to structural but also to the active functional players. Even though our study 
was limited to small number of participants; the results highlight the vast diversity of oxalate metabolizing bac-
teria in the human gut. Metabolic features, immunological response panel and disturbed trans-domain species 
correlation may give a definitive picture of hyperoxaluria condition. We hope our study would provide basic 
clues for high throughput DNA sequencing studies linking the role of gut microbiota and more information on 
trans-domain species in the development of oxalate kidney stones. Subsequently it helps to formulate the micro-
biome based biomarkers for its recurrent episodes.
Materials and Methods
Study samples and data generation. Inclusion of all the recruited subjects was based on the National 
Centre for Cell Science’s institutional ethics committee’s approval; in accordance with declaration of Helsinki 
principles. A total of seventy-two subjects were enrolled with their separate written informed consent form; 
symptomatic kidney stone diseased (n = 24) hereafter referred to as KSD, and Healthy control (n = 48) hereafter 
called HLT were involved in the present study. Subpopulations from this cohort had been already explained 
elsewhere as a case-control study11. Sample collection, processing, amplicon- and functional- metagenomic data 
generation with subsequent analysis has been explained in Supplementary File S7.
Raw sequence deposition. Eubacterial clone library sequences were deposited at NCBI GenBank with 
accession numbers KF229803-KF233412 and KF864681-KF866127. Raw sequences generated through Ion 
Torrent PGM in the present study including frc-, but-,and buk-gene as functional genes and Archaeal 16S rRNA 
gene, microeukaryotic 18S rRNA gene and fungal ITS region as trans-domain gene amplicons were deposited to 
SRA-NCBI under accession number SRP067039.
Figure 6. Diagrammatic illustration of actual observations in all tested subjects. Eubacterial species diversity 
and functional diversity was depicted using amplicon sequencing and qPCR assays. Other Trans-domain 
diversity was depicted using amplicon sequencing based analysis only. Arrow indicates the abundance level of 
trans-domain components in disease state.
www.nature.com/scientificreports/
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